CO2021010786A2 - Toxinas apxia, apxiia y apxiiia inactivadas - Google Patents
Toxinas apxia, apxiia y apxiiia inactivadasInfo
- Publication number
- CO2021010786A2 CO2021010786A2 CONC2021/0010786A CO2021010786A CO2021010786A2 CO 2021010786 A2 CO2021010786 A2 CO 2021010786A2 CO 2021010786 A CO2021010786 A CO 2021010786A CO 2021010786 A2 CO2021010786 A2 CO 2021010786A2
- Authority
- CO
- Colombia
- Prior art keywords
- toxins
- inactivated
- apxiiia
- apxia
- apxiia
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/285—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Se describen toxinas ApxIA, ApxIIA y ApxIIIA inactivadas, vacunas que comprenden dichas toxinas inactivadas y el uso de las mismas para la inmunización y protección de mamíferos.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP19154466.7A EP3689373A1 (en) | 2019-01-30 | 2019-01-30 | Inactivated apxia, apxiia and apxiiia toxins |
PCT/EP2020/052334 WO2020157222A1 (en) | 2019-01-30 | 2020-01-30 | Inactivated apxia, apxiia and apxiiia toxins |
Publications (1)
Publication Number | Publication Date |
---|---|
CO2021010786A2 true CO2021010786A2 (es) | 2021-10-29 |
Family
ID=65443641
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CONC2021/0010786A CO2021010786A2 (es) | 2019-01-30 | 2021-08-17 | Toxinas apxia, apxiia y apxiiia inactivadas |
Country Status (8)
Country | Link |
---|---|
EP (2) | EP3689373A1 (es) |
JP (1) | JP2022519204A (es) |
KR (1) | KR20210141464A (es) |
CN (1) | CN113490506A (es) |
BR (1) | BR112021014944A2 (es) |
CO (1) | CO2021010786A2 (es) |
MX (1) | MX2021009105A (es) |
WO (1) | WO2020157222A1 (es) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB202011902D0 (en) * | 2020-07-30 | 2020-09-16 | Imperial College Innovations Ltd | Antinobacillus pleuropneumoniae vaccines |
CN112704732B (zh) * | 2020-12-24 | 2022-02-25 | 华中农业大学 | 一种猪传染性胸膜肺炎放线杆菌亚单位疫苗 |
WO2022196816A1 (ja) * | 2021-03-19 | 2022-09-22 | 国立大学法人三重大学 | 急性肺障害および肺線維症の急性増悪を改善するための医薬組成物 |
CN113416666A (zh) * | 2021-04-27 | 2021-09-21 | 华中农业大学 | 猪胸膜肺炎放线杆菌血清10型突变菌株、ApxIA蛋白及应用 |
CN115960184B (zh) * | 2022-09-28 | 2023-12-12 | 华中农业大学 | 一种溶血性曼氏杆菌a6血清型白细胞毒素抗原蛋白、其抗体及应用 |
CN117883560A (zh) * | 2023-07-24 | 2024-04-16 | 华中农业大学 | 猪胸膜肺炎放线杆菌灭活亚单位联合疫苗及应用 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69110082T2 (de) | 1990-04-20 | 1995-11-09 | Akzo Nobel Nv | Untereinheit-Impfstoff gegen Actinobacillus Pleuropneumoniae. |
US5994525A (en) * | 1991-06-28 | 1999-11-30 | Kamp; Elbarte Margriet | Nucleic acid encoding Actinobacillus pleuropneumoniae cytolytic proteins |
AUPN631495A0 (en) | 1995-11-02 | 1995-11-23 | Commonwealth Scientific And Industrial Research Organisation | Vaccine and biological vector(I) |
EP0810283A3 (en) | 1996-05-31 | 1997-12-10 | Akzo Nobel N.V. | Live attenuated RTX-procucing bacteria of the family Pasteurellaceae |
US6770275B1 (en) * | 1996-05-31 | 2004-08-03 | Akzo Nobel N.V. | Live attenuated RTC-producing bacteria of the family |
ES2233145B1 (es) | 2002-11-20 | 2006-07-16 | Laboratorios Hipra, S.A. | Vacuna viva atenuada contra la pleuroneumonia porcina. |
CN101265457B (zh) * | 2007-07-20 | 2011-01-26 | 华中农业大学 | 区分疫苗免疫和野毒感染动物的猪胸膜肺炎放线杆菌血清7型双基因缺失突变株的疫苗及应用 |
ES2416154B1 (es) * | 2011-11-09 | 2015-04-01 | Laboratorios Hipra, S.A. | Cepa viva atenuada de Actinobacillus pleuropneumoniae |
-
2019
- 2019-01-30 EP EP19154466.7A patent/EP3689373A1/en not_active Withdrawn
-
2020
- 2020-01-30 KR KR1020217027540A patent/KR20210141464A/ko unknown
- 2020-01-30 CN CN202080011792.6A patent/CN113490506A/zh active Pending
- 2020-01-30 EP EP20701651.0A patent/EP3897707A1/en active Pending
- 2020-01-30 WO PCT/EP2020/052334 patent/WO2020157222A1/en unknown
- 2020-01-30 BR BR112021014944A patent/BR112021014944A2/pt unknown
- 2020-01-30 JP JP2021543459A patent/JP2022519204A/ja active Pending
- 2020-01-30 MX MX2021009105A patent/MX2021009105A/es unknown
-
2021
- 2021-08-17 CO CONC2021/0010786A patent/CO2021010786A2/es unknown
Also Published As
Publication number | Publication date |
---|---|
EP3897707A1 (en) | 2021-10-27 |
EP3689373A1 (en) | 2020-08-05 |
WO2020157222A8 (en) | 2021-09-10 |
JP2022519204A (ja) | 2022-03-22 |
KR20210141464A (ko) | 2021-11-23 |
MX2021009105A (es) | 2021-09-08 |
WO2020157222A1 (en) | 2020-08-06 |
CN113490506A (zh) | 2021-10-08 |
BR112021014944A2 (pt) | 2021-11-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO2021010786A2 (es) | Toxinas apxia, apxiia y apxiiia inactivadas | |
DOP2019000180A (es) | INHIBIDORES DE TGFß1 ISOFORMA-ESPECÍFICOS CONTEXTO-PERMISIVOS Y USO DE LOS MISMOS | |
CO2021001893A2 (es) | Anticuerpos anti-gdf15, composiciones y métodos de uso | |
CL2022000448A1 (es) | Autoinyector (divisional solicitud no. 201903061) | |
CO2018008761A2 (es) | Derivados de maitansinoide, conjugados de los mismos métodos de uso | |
BR112019012343A2 (pt) | anticorpos il-11ra | |
CL2023001550A1 (es) | Sistemas activos dinámicos acromosómicos. | |
BR112019001737A2 (pt) | expressão de pten-long com vírus oncolíticos | |
CO2021004456A2 (es) | Vacunas neumocócicas multivalentes | |
CL2017003240A1 (es) | Anticuerpos anti-rnf43 novedosos y métodos para su uso | |
CL2021000855A1 (es) | Replicones basados en alfavirus para la administración de bioterapias. | |
AR108468A1 (es) | POLIPÉPTIDOS DE FUSIÓN CD40L-Fc Y MÉTODOS DE USO DE LOS MISMOS | |
BR112018014355A2 (pt) | processos para a preparação de f-benzoxazinorifamicina i e para a preparação de 2-amino-5-fluorobenzeno-1,3-diol iii | |
CO2022008662A2 (es) | Degradadores de smarca y usos de los mismos | |
ECSP21052193A (es) | Tratamiento de cefalea por uso excesivo de medicamentos usando anticuerpos anti-cgrp o anti-cgrp-r | |
UY36217A (es) | Compuestos piridona sustituídos, composiciones farmacéuticas y métodos de uso. | |
CL2023001140A1 (es) | Formulaciones de anticuerpos anti-pd-l1 | |
CO2022009737A2 (es) | Anticuerpos anti-ly6g6d y métodos de uso | |
CL2020001856A1 (es) | Métodos para tratar la enfermedad de farber. | |
CO2017010692A2 (es) | Construcciones de calicheamicina y sus métodos de uso | |
CL2016001977A1 (es) | Composición que comprende igm derivada de plasma y su uso para el tratamiento o prevención de afecciones inmunitarias. | |
BR112018072592A2 (pt) | vetor de vacina de levedura que inclui polipeptídeos imunoestimulantes e antigênicos, e métodos de uso dos mesmos | |
BR112022009587A2 (pt) | Anticorpo anti-pcsk9 e uso do mesmo | |
CL2021002501A1 (es) | Compuestos novedosos y métodos de uso de los mismos. | |
BR112018010596A2 (pt) | anticorpos para cgrp e usos dos mesmos |